Evidence map›Paper›PMID 31412800›Full record

ArticleBMC ophthalmology2019

The diagnostic accuracy of an intelligent and automated fundus disease image assessment system with lesion quantitative function (SmartEye) in diabetic patients.

Yi Xu, Yongyi Wang, Bin Liu, Lin Tang, Liangqing Lv, Xin Ke, Saiguang Ling, Lina Lu, Haidong Zou

Abstract read
In one paragraph

Article in BMC ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yi XuShanghai Eye Disease Prevention & Treatment Center / Shanghai Eye Hospital, Shanghai Key Laboratory of Ocular Fundus Diseases; Shanghai General Hospital, Shanghai Engineering Center for Visual Science and Photomedicine, 380 Kangding Road, Shanghai, 200040, China.
Yongyi WangShenzhen Nanshan Center for Chronic Disease Control, No. 7, Huaming Road, Nanshan District, Shenzhen, 518064, China.
Bin LiuShanghai Radio Equipment Research Institute, No. 203, Liping Road, Shanghai, 200090, China.
Lin TangShanghai Radio Equipment Research Institute, No. 203, Liping Road, Shanghai, 200090, China.
Liangqing LvShanghai Radio Equipment Research Institute, No. 203, Liping Road, Shanghai, 200090, China.
Xin KeEVision technology (Beijing) Co. LTD., No.26, Shangdixinxi Road, Haidian District, Beijing, 100085, China.
Saiguang LingEVision technology (Beijing) Co. LTD., No.26, Shangdixinxi Road, Haidian District, Beijing, 100085, China.
Lina LuShanghai Eye Disease Prevention & Treatment Center / Shanghai Eye Hospital, Shanghai Key Laboratory of Ocular Fundus Diseases; Shanghai General Hospital, Shanghai Engineering Center for Visual Science and Photomedicine, 380 Kangding Road, Shanghai, 200040, China.
Haidong ZouShanghai Eye Disease Prevention & Treatment Center / Shanghai Eye Hospital, Shanghai Key Laboratory of Ocular Fundus Diseases; Shanghai General Hospital, Shanghai Engineering Center for Visual Science and Photomedicine, 380 Kangding Road, Shanghai, 200040, China. drzouhaidong@sina.com.

Funding

National Natural Science Foundation of China 81700844National Nature Science Foundation of China 81670898Research Grant of Shanghai Municipal Commission of Health and Family Planning 20164Y0237Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support 20172022The Chronic Diseases Prevention and Treatment Project of Shanghai Shen Kang Hospital Development Centre SHDC12015315The Chronic Diseases Prevention and Treatment Project of Shanghai Shen Kang Hospital Development Centre SHDC2015644The Scientific and Technological Innovation Action Plan of Science and Technology Commission of Shanghai Municipality 17511107900The Scientific and Technological Innovation Action Plan of Science and Technology Commission of Shanghai Municipality 17511107901The Shanghai Outstanding Academic Leader Program 16XD1402300The Shanghai Three Year Public Health Action Program GWIV-3.3
6 · The paper itself

Abstract

backgroundWith the diabetes mellitus (DM) prevalence increasing annually, the human grading of retinal images to evaluate DR has posed a substantial burden worldwide. SmartEye is a recently developed fundus image processing and analysis system with lesion quantification function for DR screening. It is sensitive to the lesion area and can automatically identify the lesion position and size. We reported the diabetic retinopathy (DR) grading results of SmartEye versus ophthalmologists in analyzing images captured with non-mydriatic fundus cameras in community healthcare centers, as well as DR lesion quantitative analysis results on different disease stages.

methodsThis is a cross-sectional study. All the fundus images were collected from the Shanghai Diabetic Eye Study in Diabetics (SDES) program from Apr 2016 to Aug 2017. 19,904 fundus images were acquired from 6013 diabetic patients. The grading results of ophthalmologists and SmartEye are compared. Lesion quantification of several images at different DR stages is also presented.

resultsThe sensitivity for diagnosing no DR, mild NPDR (non-proliferative diabetic retinopathy), moderate NPDR, severe NPDR, PDR (proliferative diabetic retinopathy) are 86.19, 83.18, 88.64, 89.59, and 85.02%. The specificity are 63.07, 70.96, 64.16, 70.38, and 74.79%, respectively. The AUC are PDR, 0.80 (0.79, 0.81); severe NPDR, 0.80 (0.79, 0.80); moderate NPDR, 0.77 (0.76, 0.77); and mild NPDR, 0.78 (0.77, 0.79). Lesion quantification results showed that the total hemorrhage area, maximum hemorrhage area, total exudation area, and maximum exudation area increase with DR severity.

conclusionsSmartEye has a high diagnostic accuracy in DR screening program using non-mydriatic fundus cameras. SmartEye quantitative analysis may be an innovative and promising method of DR diagnosis and grading.

Indexed as

AdultAgedAged, 80 and overCross-Sectional StudiesDiabetic RetinopathyFemaleFluorescein AngiographyFundus OculiHumansImage Processing, Computer-AssistedMaleMiddle AgedReproducibility of ResultsRetinaSeverity of Illness IndexVision ScreeningDiabetic retinopathyDigital imaging processingEpidemiologyLesion quantificationScreening

Identifiers

PMID31412800
PMCPMC6694694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.